Piper Jaffray analyst Tyler Van Buren reiterated a Neutral rating but noted he is incrementally more positive on Ionis Pharmaceuticals ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE